Tvardi Therapeutics's total assets for Q2 2025 were $43.75M, an increase of 12.33% from the previous quarter. TVRD total liabilities were $10.82M for the fiscal quarter, a -76.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.